TY - JOUR T1 - â–¼Moclobemide for depression JF - Drug and Therapeutics Bulletin JO - Drug Ther Bull SP - 6 LP - 8 DO - 10.1136/dtb.1994.3216 VL - 32 IS - 1 A2 - , Y1 - 1994/01/01 UR - http://dtb.bmj.com/content/32/1/6.abstract N2 - Relevant BNF section: 4.3.2Moclobemide (Manerix - Roche), the first of a new class of antidepressant drugs, was launched in the UK last year. It is a reversible inhibitor of monoamine oxidase A, which the manufacturer claims is a "first line treatment for major depression". Is this claim justified? ER -